Edward White Stock Analyst Profile - HC Wainwright & Co. Research Coverage - Stocknear

Edward White

Stock Analyst at HC Wainwright & Co.

(3.64)
# 2561
Out of 5,506 analysts
518
Total ratings
Success rate
Average return

46 Stocks

Name Action PT Current % Upside Ratings Updated
CGEM Cullinan Therapeutic...
Reiterates: Buy
33 33
5.9 459.32% 24 Apr 16, 2025
VALN Valneva
Reiterates: Buy
17 17
11.39 49.25% 41 Apr 15, 2025
INZY Inozyme Pharma
Reiterates: Buy
16 16
n/a n/a 14 Apr 10, 2025
NYXH Nyxoah
Reiterates: Buy
15 15
4.95 203.03% 15 Apr 8, 2025
SABS SAB Biotherapeutics
Reiterates: Buy
6 6
2.05 192.68% 15 Apr 1, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
20 16
1.65 869.7% 18 Mar 31, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 11 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
80 80
9.31 759.29% 6 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 11 Mar 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
20 20
2.95 577.97% 2 Mar 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 12 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
15 16
4.87 228.54% 7 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
22 25
6.05 313.22% 6 Mar 25, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
8 8
1.58 406.33% 25 Mar 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 2 Mar 20, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 23 Mar 7, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
11 11
n/a n/a 18 Mar 5, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
55 55
36.7 49.86% 31 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
51 51
15.6 226.92% 29 Mar 4, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
7 7
5.13 36.45% 20 Feb 28, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Strong Buy
7 56
6.38 777.74% 28 Feb 26, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Buy
31 31
10.1 206.93% 21 Feb 21, 2025
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
5 5
n/a n/a 15 Nov 8, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 12 Jul 1, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
9 3
n/a n/a 13 Jun 25, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 12 Jun 4, 2024
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Reiterates: Neutral
n/a
n/a n/a 9 May 26, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Neutral
25
n/a n/a 7 Mar 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Feb 28, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 4 Feb 3, 2023
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
101 52
n/a n/a 4 Aug 5, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
40 20
n/a n/a 4 Jun 30, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 10 May 6, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Apr 1, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Mar 21, 2022
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Neutral
n/a
n/a n/a 1 Nov 8, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
168 180
n/a n/a 7 Sep 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
700
8.28 8354.11% 3 Aug 30, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
34 30
27.64 8.54% 5 Aug 11, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
251 247
n/a n/a 14 Aug 9, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Maintains: Buy
17 15
n/a n/a 5 Aug 6, 2021
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
13 20
n/a n/a 1 Dec 10, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
n/a
n/a n/a 2 Nov 26, 2019
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Downgrades: Neutral
12
1.21 891.74% 2 Mar 6, 2018
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Buy
158
n/a n/a 3 Oct 12, 2017
XXXX
XXXXXXXXXXXXXXXX
Upgrade
Initiates Coverage On: Outperform
10
n/a n/a 1 May 24, 2017